(Q58089680)
Statements
Using ALBI score at the start of sorafenib treatment to predict regorafenib treatment candidates in patients with hepatocellular carcinoma (English)
Atsushi Yukimoto
Masashi Hirooka
Atsushi Hiraoka
Kojiro Michitaka
Hironori Ochi
Kouji Joko
Yusuke Imai
Takao Watanabe
Yohei Koizumi
Osamu Yoshida
Masanori Abe